Crossmark

Efficacy of propofol-supplemented cardioplegia on biomarkers of organ injury in patients having cardiac surgery using cardiopulmonary bypass: a statistical analysis plan for the ProMPT-2 randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-024-08016-w

Published Online: 2024-02-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Smartt, Helena http://orcid.org/0000-0001-5285-2262
Angelini, Gianni D. http://orcid.org/0000-0002-1753-3730
Gibbison, Ben http://orcid.org/0000-0003-3635-6212
Rogers, Chris A. http://orcid.org/0000-0002-9624-2615
Funding

Funding for this research was provided by:

Efficacy and Mechanism Evaluation Programme (15/180/55)
License Information

Text and Data Mining valid from 2024-02-29

Version of Record valid from 2024-02-29
More Information

Article History

Received: 30 October 2023

Accepted: 22 February 2024

First Online: 29 February 2024

Declarations

:

: The trial received research ethics approval from South Central – Berkshire B Research Ethics Committee (IRAS ref: 234266, REC ref: 8/SC/0472) and Medicines and Healthcare products Regulatory Agency (EUDRACT ref: 2018-000169-35) in September 2018. Patients provided written informed consent for use of their data.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below